surmount-1 tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO trial investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Can Tirzepatide Help You Lose

No, hot flushes are not listed among the common, uncommon, or rare side effects in the UK Summary of Product Characteristics for Mounjaro

Not Losing Weight on Mounjaro

Not everybody who thinks they need one of these drugs actually needs them

Hence, it is essential to take your healthcare provider onboard before including any new supplement into your diet or making any kind of lifestyle alterations, especially when you are dealing with certain health conditions or are pregnant

While renin-angiotensin system (RAS) and sodium glucose cotransporter 2 (SGLT2) inhibitors reduce CKD progression and cardiovascular risks, residual risks remain, especially with high albuminuria